This webinar, organised by US TOO Int. and recorded on July 29th, is a discussion on the topic of Genetics and Genomics. Genetics and genomics technology is changing rapidly and there are a growing number of options available to help guide prostate cancer treatment decisions.

View the Video here.

The EAU Patient Information published new, accessible prostate cancer content especially for patients.

After the summer vacation period, the Board will have its next virtual meeting on Friday, September 10th.

What is immunotherapy?
Immunotherapy uses a person’s own immune system to fight cancer, basically drugs encourage the body’s own immune system to attack the disease. Unfortunately, immunotherapies do not work for all patients.

The Immune-Image project, jointly funded by EU and EFPIA (GA831514), aims to develop different methods to study the immune cells involved before, during, and after treatments allowing selection of the right treatment for the right patient at the right time.

ECPC (the European Cancer Patient Coalition) supports communication and dissemination of the Immune-Image project’s outcomes towards cancer patients and cancer organisations. We are happy to announce that with support of the project partners, Immune-Image developed several translations of the patient brochure and video that is now available.

Discover more about immunotherapy, its benefits and the project in the patient brochure which is translated in Finnish, Italian, Romanian, Slovak, Dutch, Slovenian, Spanish, Swedish, German and French language.

The video is also available in Finnish, Italian, French, Romanian, Slovak, Dutch, Slovenian, Spanish, Swedish and German.

Active Surveillance Patients International (ASPI) will focus again on transperineal vs. transrectal biopsies.

The session will be at 12:00-1:30 pm ET (or 06:00-07:30 pm CET) on August 28.

The program will feature Agnes Gulbrandsen, a Norwegian hairdresser, who wanted to know why her father died from a brain clot days after undergoing a transrectal prostate biopsy. This is a story of how one voice made a profound difference in saving men’s lives diagnosed with PCa.

The doctors dismissed her until her father’s urologist Dr. Truls Bjerklund Johansen proved the link and did a study showing that patients could avoid sepsis and infections by undergoing transperineal procedures.

Dr. Rick Popert will describe the success in the United Kingdom in abandoning the transrectal biopsy and moving to the safer transpertineal biopsy.

Dr. Jeremy Grummet, an Australian urologist, will talk about how his country’s health plan is encouraging transperineal biopsies.

The discussion will be followed by a question-and-answer period.

Register in advance here.